- Home
- KYMR vs INDB Comparison
KYMR vs INDB Comparison
Compare KYMR & INDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KYMR
- INDB
- Stock Information
- Founded
- KYMR 2015
- INDB 1907
- Country
- KYMR United States
- INDB United States
- Employees
- KYMR N/A
- INDB N/A
- Industry
- KYMR Medicinal Chemicals and Botanical Products
- INDB Major Banks
- Sector
- KYMR Health Care
- INDB Finance
- Exchange
- KYMR Nasdaq
- INDB Nasdaq
- Market Cap
- KYMR 3.1B
- INDB 3.5B
- IPO Year
- KYMR 2020
- INDB N/A
- Fundamental
- Price
- KYMR $43.51
- INDB $71.09
- Analyst Decision
- KYMR Strong Buy
- INDB Buy
- Analyst Count
- KYMR 15
- INDB 3
- Target Price
- KYMR $58.53
- INDB $71.00
- AVG Volume (30 Days)
- KYMR 722.6K
- INDB 280.5K
- Earning Date
- KYMR 10-30-2025
- INDB 10-16-2025
- Dividend Yield
- KYMR N/A
- INDB 3.33%
- EPS Growth
- KYMR N/A
- INDB N/A
- EPS
- KYMR N/A
- INDB 4.43
- Revenue
- KYMR $44,711,000.00
- INDB $662,753,000.00
- Revenue This Year
- KYMR $58.45
- INDB $33.33
- Revenue Next Year
- KYMR N/A
- INDB $21.54
- P/E Ratio
- KYMR N/A
- INDB $16.00
- Revenue Growth
- KYMR N/A
- INDB N/A
- 52 Week Low
- KYMR $19.45
- INDB $52.15
- 52 Week High
- KYMR $53.27
- INDB $77.23
- Technical
- Relative Strength Index (RSI)
- KYMR 53.28
- INDB 60.66
- Support Level
- KYMR $39.84
- INDB $68.07
- Resistance Level
- KYMR $43.43
- INDB $72.56
- Average True Range (ATR)
- KYMR 2.03
- INDB 1.91
- MACD
- KYMR 0.15
- INDB 0.18
- Stochastic Oscillator
- KYMR 78.76
- INDB 74.77
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of, differentiated medicines that address health problems and that meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.
About INDB Independent Bank Corp.
Independent Bank Corp is a bank holding company and the sole shareholder of its bank, the Rockland Trust Company. Rockland is a community-oriented commercial bank. The bank provides a variety of banking, investment and financial services, operating with various retail branches, as well as a network of commercial and residential lending centers and investment management offices majorly in Eastern Massachusetts, Worcester County, and Rhode Island. The bank's loan portfolio constitutes the bulk of the bank's total assets. Its borrowers consist mostly of small to medium-size businesses and consumers, majority of which are made to its market area in eastern Massachusetts and Rhode Island. The bank's loan portfolio is predominantly in commercial loans.